secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0001104659-24-122379
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TransCode shareholders approve 10M share offering and reverse stock split at special meeting
--------------------------------------------------------------------------------

- Ratified issuance of 10M shares of common stock and warrants to ThinkEquity LLC via best-efforts public offering.
- Approved reverse stock split at ratio between 1:10 and 1:40, with timing at Board's discretion.
- Ratification Proposal: 3,659,491 for, 1,094,753 against, 70,611 abstain (4,655,205 broker non-votes).
- Reverse Stock Split Proposal: 7,271,421 for, 2,012,687 against, 195,952 abstain; no broker non-votes.
- Adjournment Proposal approved but not needed; total shares present at meeting: 9,480,060 of 17,265,658 entitled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465924122379/0001104659-24-122379-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465924122379/tm2429410d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-122379

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer